Abstract
As systemic therapies advance in the management of lung cancer, the control of intracranial disease and the long-term toxicities associated with therapies to control intracranial disease becomes more relevant. This chapter reviews multiple aspects of intracranial metastatic disease from lung cancer, with a focus on randomized data which have guided therapy. In addition, we will highlight areas requiring further investigation.
Original language | English (US) |
---|---|
Title of host publication | Lung Cancer |
Subtitle of host publication | Fourth Edition |
Publisher | Wiley-Blackwell |
Pages | 572-589 |
Number of pages | 18 |
ISBN (Electronic) | 9781118468791 |
ISBN (Print) | 9781118468746 |
DOIs | |
State | Published - May 27 2014 |
Keywords
- Biomarkers
- Brain metastases
- Prophylactic cranial irradiation
- Stereotactic radiosurgery
- Toxicity
- Whole brain radiotherapy
ASJC Scopus subject areas
- General Medicine